February 8th Premarket Gainers

Nemaura Medical Inc. (NASDAQ: NMRD) shares rose 96.4% to $13.63 in pre-market trading. Nemaura Medical last week appointed Jay Warner as head of U.S. commercial operations. Ocugen, Inc. (NASDAQ: OCGN) shares rose 74.3% to $9.15 in pre-market trading after announcing the sale of 3 million common shares at $7.65 per share in a registered direct offering, with gross proceeds…

January 25th Premarket Gainers

TS Innovation Acquisitions Corp. (NASDAQ: TSIA) shares rose 79% to $18.50 in pre-market trading. Latch and TS Innovation Acquisitions disclosed that they have entered into a definitive merger agreement that will result in Latch becoming a publicly listed company. VYNE Therapeutics Inc. (NASDAQ: VYNE) shares rose 69.2% to $3.18 in pre-market trading. VYNE Therapeutics, last week, announced contract execution…

January 21st Watchlist

Ventures, Inc (NASDAQ: BBIG) shares rose 225% to $5.01 in pre-market trading following a report of reverse merger. The company said on Jan 20, the company and Vinco Acquisition Corp entered into a deal with Zash Global Media and Entertainment Corp. Addex Therapeutics Ltd (NASDAQ: ADXN) shares rose 128% to $24.05 in pre-market trading after the company disclosed that its…

January 20th Premarket Gainers

Caladrius Biosciences, Inc. (NASDAQ: CLBS) rose 132.4% to $3.79 in pre-market trading. Caladrius Biosciences said it treated first patient in Phase 2b FREEDOM trial of CLBS16 for the treatment of coronary microvascular dysfunction. Steel Connect, Inc. (NASDAQ: STCN) rose 79% to $1.95 in pre-market trading after climbing over 36% on Tuesday. Lineage Cell Therapeutics, Inc. (NYSE: LCTX) shares rose 62% to…